(Q43622329)

English

Comparison of the cost-effectiveness of budesonide and sodium cromoglycate in the management of childhood asthma in everyday clinical practice

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Comparison of the cost-effectiveness of budesonide and sodium cromoglycate in the management of childhood asthma in everyday clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

0 references

author name string

Andersson F

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kjellman M

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Forsberg G

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Möller C

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Arheden L

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

537-544

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The costs of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An economic evaluation of asthma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A national estimate of the economic costs of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Making cost assessments based on RCTs more useful to decision-makers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Methodological issues in economic assessments of new therapies. The case of colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical analysis in pharmacoeconomic studies. A review of current issues and standards.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical analysis of cost outcomes in a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the cost effectiveness of alternative prophylactic therapies in childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of inhaled corticosteroids on asthma hospitalization in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Advantages of high-dose inhaled budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962902-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)62902-X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43622329&oldid=2101943585"